Delaware’s top court ruled in GSK’s favor in saying it will review the admissibility of expert evidence in an upcoming trial ...

GSK has won its latest trial over whether its former best-selling ... known as NDMA that had been found in GSK’s heartburn ...

(Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness ...

GSK Plc shares rose on Wednesday, buoyed by a US court’s decision to review whether evidence supporting claims that heartburn ...

Twelve days after GSK secured a key win in Florida, with a state court tossing expert testimony on the cancer-causing ...

GSK Plc got approval from Delaware’s top court Tuesday to quickly appeal a ruling allowing expert testimony at trial over ...

UK-based GlaxoSmithKline PLC (GB:GSK) has won the latest U.S. trial concerning its heartburn drug Zantac (ranitidine), amid litigation over alleged cancer risks. The Florida State Court ruled in ...

(Reuters) – GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman’s illness, a ...